Literature DB >> 17785474

Toll-like receptor 2 controls the gamma interferon response to Francisella tularensis by mouse liver lymphocytes.

Kee-Jong Hong1, Jason R Wickstrum, Hung-Wen Yeh, Michael J Parmely.   

Abstract

The production of gamma interferon (IFN-gamma) is a key step in the protective innate immune response to Francisella tularensis. Natural killer cells and T cells in the liver are important sources of this cytokine during primary F. tularensis infections, and interleukin-12 (IL-12) appears to be an essential coactivating cytokine for hepatic IFN-gamma expression. The present study was undertaken to determine whether or not macrophages (Mphi) or dendritic cells (DC) provide coactivating signals for the liver IFN-gamma response in vitro, whether IL-12 mediates these effects, and whether Toll-like receptor (TLR) signaling is essential to induce this costimulatory activity. Both bone marrow-derived Mphi and DC significantly augmented the IFN-gamma response of F. tularensis-challenged liver lymphocytes in vitro. While both cell types produced IL-12p40 in response to F. tularensis challenge, only DC secreted large quantities of IL-12p70. DC from both IL-12p35-deficient and TLR2-deficient mice failed to produce IL-12p70 and did not costimulate liver lymphocytes for IFN-gamma production in response to viable F. tularensis organisms. Conversely, liver lymphocytes from TLR2-deficient mice cocultured with wild-type accessory cells produced IFN-gamma at levels comparable to those for wild-type hepatic lymphocytes. These findings indicate that TLR2 controls hepatic lymphocyte IFN-gamma responses to F. tularensis by regulating DC IL-12 production. While Mphi also coinduced hepatic IFN-gamma production in response to F. tularensis, they did so in a fashion less dependent on TLR2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17785474      PMCID: PMC2168295          DOI: 10.1128/IAI.00561-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity.

Authors:  C M Bosio; K L Elkins
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon.

Authors:  V C Dreisbach; S Cowley; K L Elkins
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

3.  Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS.

Authors:  J Wayne Conlan; Rhonda KuoLee; Hua Shen; Ann Webb
Journal:  Microb Pathog       Date:  2002-03       Impact factor: 3.738

4.  Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations.

Authors:  Zhe-Xiong Lian; Tomoyuki Okada; Xiao-Song He; Hiroto Kita; Yong-Jun Liu; Aftab A Ansari; Kentaro Kikuchi; Susumu Ikehara; M Eric Gershwin
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

5.  Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies.

Authors:  J Wayne Conlan; Wangxue Chen; Hua Shen; Ann Webb; Rhonda KuoLee
Journal:  Microb Pathog       Date:  2003-05       Impact factor: 3.738

Review 6.  Tularemia.

Authors:  Jill Ellis; Petra C F Oyston; Michael Green; Richard W Titball
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

Review 7.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

8.  Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS.

Authors:  G Sandström; A Sjöstedt; T Johansson; K Kuoppa; J C Williams
Journal:  FEMS Microbiol Immunol       Date:  1992-10

Review 9.  Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain.

Authors:  Karen L Elkins; Siobhán C Cowley; Catharine M Bosio
Journal:  Microbes Infect       Date:  2003-02       Impact factor: 2.700

10.  Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors.

Authors:  Siobhán C Cowley; Karen L Elkins
Journal:  J Exp Med       Date:  2003-07-28       Impact factor: 14.307

View more
  22 in total

Review 1.  IL12Rβ1: the cytokine receptor that we used to know.

Authors:  Richard T Robinson
Journal:  Cytokine       Date:  2014-12-13       Impact factor: 3.861

Review 2.  IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDS.

Authors:  Govardhana Rao Yannam; Tanuja Gutti; Larisa Y Poluektova
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-24       Impact factor: 4.147

3.  Francisella tularensis LVS-induced Interleukin-12 p40 cytokine production mediates dendritic cell migration through IL-12 Receptor β1.

Authors:  Samantha R Slight; Yinyao Lin; Michelle Messmer; Shabaana A Khader
Journal:  Cytokine       Date:  2011-06-12       Impact factor: 3.861

4.  Delineation of the role of Toll-like receptor signaling during peritonitis by a gradually growing pathogenic Escherichia coli.

Authors:  Cornelis van 't Veer; Petra S van den Pangaart; Daniëlle Kruijswijk; Sandrine Florquin; Alex F de Vos; Tom van der Poll
Journal:  J Biol Chem       Date:  2011-06-20       Impact factor: 5.157

5.  Identification of an essential Francisella tularensis subsp. tularensis virulence factor.

Authors:  Aiping Qin; David W Scott; Jennifer A Thompson; Barbara J Mann
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

6.  Francisella tularensis induces extensive caspase-3 activation and apoptotic cell death in the tissues of infected mice.

Authors:  Jason R Wickstrum; Sirosh M Bokhari; Jeffrey L Fischer; David M Pinson; Hung-Wen Yeh; Rebecca T Horvat; Michael J Parmely
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

7.  Francisella tularensis invasion of lung epithelial cells.

Authors:  Robin R Craven; Joshua D Hall; James R Fuller; Sharon Taft-Benz; Thomas H Kawula
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

8.  Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis.

Authors:  Yinyao Lin; Shane Ritchea; Alison Logar; Samantha Slight; Michelle Messmer; Javier Rangel-Moreno; Lokesh Guglani; John F Alcorn; Heather Strawbridge; Sang Mi Park; Reiko Onishi; Nikki Nyugen; Michael J Walter; Derek Pociask; Troy D Randall; Sarah L Gaffen; Yoichiro Iwakura; Jay K Kolls; Shabaana A Khader
Journal:  Immunity       Date:  2009-10-22       Impact factor: 31.745

9.  Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice.

Authors:  Ping Zhang; Jenny Katz; Suzanne M Michalek
Journal:  Mol Immunol       Date:  2008-10-17       Impact factor: 4.407

10.  TLR-dependent control of Francisella tularensis infection and host inflammatory responses.

Authors:  Allison L Abplanalp; Ian R Morris; Bijaya K Parida; Judy M Teale; Michael T Berton
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.